Rani Therapeutics Holdings Inc (NASDAQ:RANI) shares, rose in value on Wednesday, February 12, with the stock price up by 19.86% to the previous day’s close as strong demand from buyers drove the stock to $1.69.
Actively observing the price movement in the last trading, the stock closed the session at $1.41, falling within a range of $1.42 and $1.7. The value of beta (5-year monthly) was 0.114. Referring to stock’s 52-week performance, its high was $8.75, and the low was $1.24. On the whole, RANI has fluctuated by 30.00% over the past month.
With the market capitalization of Rani Therapeutics Holdings Inc currently standing at about $97.05 million, investors are eagerly awaiting this quarter’s results, scheduled for in March.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that RANI’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of RANI currently trading nearly 17.89% and 10.96% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 61.02, while the 7-day volatility ratio is showing 14.20% which for the 30-day chart, stands at 7.73%. Furthermore, Rani Therapeutics Holdings Inc (RANI)’s beta value is 0.16, and its average true range (ATR) is 0.13.
A comparison of Rani Therapeutics Holdings Inc (RANI) with its peers suggests the former has fared considerably weaker in the market. RANI showed an intraday change of 19.86% in last session, and over the past year, it shrunk by -55.41%%.
Data on historical trading for Rani Therapeutics Holdings Inc (NASDAQ:RANI) indicates that the trading volumes over the past 10 days have averaged 3.87 and over the past 3 months, they’ve averaged 1.03 million. According to company’s latest data on outstanding shares, there are 29.81 million shares outstanding.
Nearly 31.51% of Rani Therapeutics Holdings Inc’s shares belong to company insiders and institutional investors own 14.84% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 1.49 million shares as on 2024-10-31, resulting in a short ratio of 0.36. According to the data, the short interest in Rani Therapeutics Holdings Inc (RANI) stood at 772.00 of shares outstanding as of 2024-10-31; the number of short shares registered in 2024-09-30 reached 0.79 million. The stock has risen by 23.36% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the RANI stock heading into the next quarter.
